These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7603543)

  • 21. Metabolism, Pharmacokinetics, and Pharmacodynamics of Drugs of Abuse. Proceedings of a meeting. November 4-5, 1994.
    NIDA Res Monogr; 1997; 173():1-304. PubMed ID: 9297130
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of drugs of abuse on social behaviour: a review of animal models.
    Blanco-Gandía MC; Mateos-García A; García-Pardo MP; Montagud-Romero S; Rodríguez-Arias M; Miñarro J; Aguilar MA
    Behav Pharmacol; 2015 Sep; 26(6):541-70. PubMed ID: 26221831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroadaptive effects of active versus passive drug administration in addiction research.
    Jacobs EH; Smit AB; de Vries TJ; Schoffelmeer AN
    Trends Pharmacol Sci; 2003 Nov; 24(11):566-73. PubMed ID: 14607079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications.
    Volkow ND; Fowler JS; Wang GJ; Swanson JM
    Mol Psychiatry; 2004 Jun; 9(6):557-69. PubMed ID: 15098002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How it all starts inside your brain.
    Begley S
    Newsweek; 2001 Feb; 137(7):40-2. PubMed ID: 11246720
    [No Abstract]   [Full Text] [Related]  

  • 26. Gene expression induced by drugs of abuse.
    Rhodes JS; Crabbe JC
    Curr Opin Pharmacol; 2005 Feb; 5(1):26-33. PubMed ID: 15661622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The forensic application of testing hair for drugs of abuse.
    Miller ML; Donnelly B; Martz RM
    NIDA Res Monogr; 1997; 167():146-60. PubMed ID: 9243561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical toxicology of emerging drugs of abuse--an update.
    Meyer MR; Peters FT
    Ther Drug Monit; 2012 Dec; 34(6):615-21. PubMed ID: 23131695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the neurobiology, assessment, and treatment of substances of abuse and dependence: a guide for the critical care nurse.
    Genung V
    Crit Care Nurs Clin North Am; 2012 Mar; 24(1):117-30. PubMed ID: 22405717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PET and drug research and development.
    Fowler JS; Volkow ND; Wang GJ; Ding YS; Dewey SL
    J Nucl Med; 1999 Jul; 40(7):1154-63. PubMed ID: 10405137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional studies in substance abuse: imaging and beyond.
    Levin JM; Kaufman MJ
    J Nucl Med; 1995 Jul; 36(7):1298-300. PubMed ID: 7790959
    [No Abstract]   [Full Text] [Related]  

  • 32. The addicted brain: imaging neurological complications of recreational drug abuse.
    Montoya-Filardi A; Mazón M
    Radiologia; 2017; 59(1):17-30. PubMed ID: 27773463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term alterations in vulnerability to addiction to drugs of abuse and in brain gene expression after early life ethanol exposure.
    Barbier E; Pierrefiche O; Vaudry D; Vaudry H; Daoust M; Naassila M
    Neuropharmacology; 2008 Dec; 55(7):1199-211. PubMed ID: 18713641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacodynamic drug interactions: implications for abuse liability testing.
    Sellers EM; Busto U; Kaplan HL
    NIDA Res Monogr; 1989; 92():287-306. PubMed ID: 2512498
    [No Abstract]   [Full Text] [Related]  

  • 35. The economics of drug abuse: a quantitative assessment of drug demand.
    Hursh SR; Galuska CM; Winger G; Woods JH
    Mol Interv; 2005 Feb; 5(1):20-8. PubMed ID: 15731502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs of abuse and increased risk of psychosis development.
    Gururajan A; Manning EE; Klug M; van den Buuse M
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1120-35. PubMed ID: 22833579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of drug testing as an early warning programme: the experience of the Republic of Korea.
    Chung H
    Bull Narc; 2005; 57(1-2):231-48. PubMed ID: 21338024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Imaging brain function with autoradiography and positron emission tomography].
    Kato M; Hosokawa S; Kuwabara Y
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1182-91. PubMed ID: 1972583
    [No Abstract]   [Full Text] [Related]  

  • 39. Autoradiographic approaches to studying hallucinogens or other drugs.
    Appel NM
    NIDA Res Monogr; 1994; 146():214-40. PubMed ID: 8742801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Underestimation of substance abuse in psychiatric patients by conventional hospital screening.
    Reidy LJ; Junquera P; Van Dijck K; Steele BW; Nemeroff CB
    J Psychiatr Res; 2014 Dec; 59():206-12. PubMed ID: 25262418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.